Johnson & Johnson’s Acuvue contact lens shows efficacy in studies

Johnson & Johnson announced new data on the Acuvue Oasys Max 1-Day for Astigmatism contact lenses which showed higher end-of-day comfort as compared to Dailies Total1 for Astigmatism. The data will be presented at the American Academy of Optometry’s annual meeting in Boston. Other data being showcased includes Acuvue Oasys Max Multifocal for Astigmatism extends daily disposable multifocal contact lens options to a new population of presbyopic patients. Patient reported vision outcomes for two daily disposable toric soft contact lenses research showed that 62% of patients preferred Acuvue Oasys Max for Astigmatism for overall vision versus only 18% who preferred Dailies Total1 for Astigmatism. Acuvue Oasys Max for Astigmatism was consistently rated higher for overall opinion and all comfort metrics. When asked about vision on computer screens and digital device use, 65% preferred the Acuvue Oasys Max for Astigmatism lens, while only 16% preferred Dailies Total1 for Astigmatism. When Acuvue Oasys Max for Astimgatism was worn second, positive feedback of overall opinion increased to 80.0% versus 33.3% for Dailies Total1 for Astigmatism. The new multifocal toric lens therefore extends the coverage by daily disposable multifocal contact lenses to a new population of presbyopic patients.